Morbidity and mortality of cardiovascular diseases (CVDs) are exceedingly high worldwide.
Researchers have found that the occurrence and development of CVDs are closely related …

Trimethylamine (TMA) is a gut microbiota-derived metabolite which comes from diets rich of
choline, betaine or l-carnitine and could be further converted to Trimethylamine-N-oxide …

Trimethylamine-N-oxide (TMAO) is the main diet-induced metabolite produced by the gut
microbiota, and it is mainly eliminated through renal excretion. TMAO has been correlated …

There is increasing appreciation that changes in microbiome composition and function can
promote long-term susceptibility for cardiometabolic risk. Gut microbe-derived metabolites …

Trimethylamine N-oxide (TMAO) is a biologically active molecule and is a putative promoter
of chronic diseases including atherosclerosis in humans. Host intestinal bacteria produce its …

Recent evidence, including massive gene-expression analysis and a wide-variety of other
multi-omics approaches, demonstrates an interplay between gut microbiota and the …

Atherosclerosis is associated with various pathological manifestations, such as ischemic
heart disease, ischemic stroke, and peripheral arterial disease, and remains a leading …

The extensive collection of bacteria cohabiting within the host collaborates with human
functions and metabolisms in both health and disease. The fine equilibrium of commensals …

Cardiovascular disease (CVD) is a serious disease that endangers human health and is one
of the leading causes of death. Recent studies have reported that gut microbiota plays an …

Trimethylamine N-oxide (TMAO) is a biologically active gut microbiome-derived dietary
metabolite. Recent studies have shown that high circulating plasma TMAO levels are closely …